Ranevetmab
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1632282-27-9
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Caninized IgG1 kappa
Canlupfam
|
NGF |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Dogs with degenerative joint disease (DJD) pain[2]
-
Dosage:200 μg/kg
-
Administration:i.v.
-
Result:Improved canine brief pain inventory (CBPI), pain severity (PS) and pain interference (PI) scores.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1632282-27-9
-
SMILES
[Ranevetmab]
-
Synonyms
NV-01
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)